Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
MBX Biosciences’ $187.7 Million IPO
TPI Composites, Inc.’s Refinancing Transaction with Oaktree
Lazard acted as TPI’s financial advisor. Goodwin Procter LLP acted as TPI’s legal advisor and Sullivan & Cromwell LLP acted as Oaktree’s legal advisor. TPI Composites,...
Palo Alto Network’s Acquisition of Talon Cyber Security
Goodwin Procter acted as US counsel to Talon Cyber Security in the definitive agreement to be acquired by Palo Alto Network. Palo Alto Networks has acquired...
Coherus’ Acquisition of Surface Oncology
Arnold & Porter advised Coherus Biosciences Inc. on the deal, and Goodwin advised Surface Oncology. Coherus Biosciences Inc. (Coherus) announced its acquisition of Surface Oncology Inc. (Surface),...
Silver Lake and CPP Investments’ $12.5 Billion Acquisition of Qualtrics International
Goodwin Procter advised Qualtrics International Inc. on the deal. Qualtrics International Inc. (NASDAQ: XM) announced its definitive agreement to be acquired by Silver Lake, in partnership...
Sun Pharmaceutical’s $576 Million Acquisition of Concert Pharmaceuticals
Davis Polk advised Sun Pharmaceutical, and Goodwin Procter advised Concert Pharmaceuticals. Sun Pharmaceutical Industries Limited announced its acquisition of Concert Pharmaceuticals Inc., through a tender offer for an...
KVH Industries’ Asset Purchase Agreement with EMCORE Corporation
Goodwin Procter advised KVH Industries on the deal while Pillsbury advised EMCORE Corporation. KVH Industries, Inc. (NASDAQ: KVHI) announced its asset purchase agreement with EMCORE Corporation....
Collegium Pharmaceutical’s Acquisition of BioDelivery Sciences International
Goodwin Procter advised BioDelivery Sciences International on the deal while Troutman Pepper advised Collegium Pharmaceutical. BioDelivery Sciences International (NASDAQ: BDSI) announced its definitive merger agreement to be...
PointClickCare Technologies’ Acquisition of Audacious Inquiry
Goodwin Procter advised Audacious Inquiry on the deal. Audacious Inquiry announced its agreement to be acquired by PointClickCare Technologies. Audacious Inquiry is a national industry-shaping health IT...
Cast & Crew’s Acquisition of Backstage Holdings
Latham & Watkins represented Cast & Crew in the transaction while Goodwin advised TA Associates and Backstage Holdings. Cast & Crew, a leading end-to-end cloud-based platform...
Permira’s Investment in BPL and Kedrion
Goodwin Procter advised Bio Products Laboratory and Tiancheng International Investment Limited on the deal. The shareholders of Kedrion was advised by Carnelutti and Pedersoli Studio Legale,...
Amylyx Pharmaceuticals’ $190 Million IPO
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal while Goodwin Procter represented Amylyx Pharmaceuticals. Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company...